Why Carry a Product You Can Explain at the Molecular Level
The informed patient market is real and growing. Patients presenting for regenerative medicine consultations increasingly arrive having read the peer-reviewed literature, having watched educational content, and asking specific questions about passage number, culture system, and COA documentation. The practitioners best positioned in this environment are those who can engage those questions with confidence — because they have done the same work.
The 3DMSCS certification program is not marketing training. It is a clinical education program grounded in peer-reviewed science. It covers what MSCs actually are, how 3D spheroid culture changes the secretome and why, what xenofree manufacturing requires and why it matters for batch consistency, how passage accumulation affects exosome cargo, what ISCT criteria do and do not tell you, and how to interpret a COA. Practitioners who complete the program understand the product at the same level as the scientists who characterize it.
The core argument: Particle count is the least important number on a COA. Culture system, passage number, and media type are the variables that determine what is inside those particles. A practitioner who can explain this to a patient is differentiated. A practitioner who cannot is interchangeable.
What Certification Covers: Six Modules
-
MOD 1
MSC Biology and In Vivo Niche
What mesenchymal stem cells are, where they reside in vivo, their perivascular niche architecture, their immunomodulatory mechanisms (IDO, PGE2, TSG-6, HLA-G, exosome-mediated), and why the in vivo context is the biological reference standard for evaluating any ex vivo preparation.
-
MOD 2
Xenofree Manufacturing Science
FBS composition, bovine protein incorporation mechanism, FBS-derived EV contamination and its quantitative scale, alpha-Gal immunogenicity, batch inconsistency from lot-to-lot FBS variation, and what chemically defined xenofree manufacturing requires — including recombinant growth factor substitutes, synthetic attachment matrices, and validation protocols.
-
MOD 3
Passage Number, Potency, and SASP
What a passage is, the Hayflick limit and replicative senescence biology, the four-phase passage trajectory (isolation, peak activity P2-P4, transition P5-P7, SASP P8+), SASP factor profile (IL-6, IL-8, MMP-1, MMP-3, IGFBP-7), what high-passage exosomes carry, HLA-DR upregulation, and the commercial disclosure problem with passage number in the market.
-
MOD 4
Characterization: ISCT, Beyond ISCT, and COA Requirements
ISCT surface marker criteria and what each marker means functionally, why a senescent P15 MSC still passes ISCT criteria, MLR immunosuppression assay, CFU-F efficiency, SA-beta-gal and p21/p16 senescence markers, MISEV2018 EV characterization standards, the full COA minimum for a clinical-grade exosome preparation, and the practitioner procurement checklist.
-
MOD 5
Regulatory Framework
FDA HCT/P regulations and the 361/351 product distinction as it applies to cell and EV-based preparations, IND requirements and CMC expectations for EV products, state licensure considerations for administering exosome preparations, the EMA ATMP framework and xenofree expectations, and how to position educational conversations with patients within appropriate regulatory boundaries.
-
MOD 6
Product Science and Clinical Application
3DMSCS product specifications in detail, lot-by-lot COA interpretation, cold chain requirements, freeze-thaw protocols, stability data, how to discuss the product with patients using accurate scientific language, and practice integration including informed consent documentation, patient selection considerations, and outcome tracking.
Provider Network Advantages
Referral Network
Certified providers are listed in the public provider directory where informed patients actively search for practitioners. Patients who have done the research — and who are asking the right questions about passage number and xenofree manufacturing — find certified providers first.
Exclusive Product Access
The 3DMSCS preparation is available exclusively to certified practitioners. Product access is contingent on completing and maintaining certification, ensuring that every provider carrying this product understands what they are representing to patients.
Continuing Education
The science of MSC biology and exosome characterization continues to evolve. Certified providers receive ongoing education updates as new peer-reviewed literature emerges, regulatory guidance updates, and manufacturing science advances. Certification is maintained through annual continuing education.
Practice Development Support
Certified providers receive access to patient education materials grounded in the peer-reviewed literature, consultation on practice integration, and support for informed consent documentation that accurately represents the science and regulatory status of the preparation.
Who This Program Is For
The 3DMSCS certification program is designed for licensed healthcare practitioners with:
- Active licensure in good standing in their state of practice
- Legal scope to administer or supervise administration of injectable preparations
- An existing or developing regenerative medicine practice, or interest in adding a well-characterized exosome preparation to an existing functional, integrative, orthopedic, or sports medicine practice
- Commitment to science-based patient education and accurate representation of regulatory status
Eligible credential types include, but are not limited to: MD, DO, ND, DC, NP (with appropriate scope), PA-C, and DDS/DMD in oral and maxillofacial applications. Eligibility is confirmed during application review based on licensure documentation and state-specific scope considerations.
Product Specifications
The preparation available to certified practitioners:
3DMSCS Extracellular Vesicle Preparation
| Specification | Value |
|---|---|
| Particle count per vial | 60 billion EVs |
| Culture system | 3D spheroid |
| Media | Xenofree, chemically defined throughout |
| Passage at harvest | P2-P4 |
| Tissue source | Human umbilical cord MSCs |
| Tetraspanin status | CD9+, CD63+, CD81+ confirmed by COA |
| Sterility | USP 71 tested, lot release |
| Endotoxin | <1.0 EU/mL, LAL-tested, lot release |
| Mycoplasma | PCR negative, lot release |
Application Process
Submit Application
Complete the application form below. Include current licensure information, specialty, and a description of your current regenerative medicine practice or interest. Applications are reviewed within 5-7 business days.
Licensure Verification
We verify your license status in your state of practice. Active, unrestricted licensure is required. This step is typically completed within 48 hours of application review.
Complete the Six-Module Education Program
Self-paced online modules covering the full science and regulatory framework. Estimated completion time is 4-6 hours. Assessment at the end of each module confirms comprehension of the material.
Certification Review
Module assessments are reviewed by our clinical education team. Practitioners meeting the competency standard are issued certification. Those who need additional review receive targeted follow-up resources.
Product Access and Directory Listing
Certified practitioners are onboarded to the ordering platform, listed in the public provider directory, and provided with patient education materials. Annual continuing education maintains certification status.
Practitioner Application
Complete all fields. Applications with incomplete licensure information cannot be reviewed.
Frequently Asked Questions for Practitioners
What credentials are required to apply for certification?
Active licensure as a physician (MD/DO), naturopathic doctor (ND), chiropractor (DC), nurse practitioner (NP), physician assistant (PA), or other licensed healthcare professional with legal scope to administer or supervise administration of injectable preparations in their state. Eligibility is confirmed during licensure verification based on state-specific scope of practice rules.
Is there a cost for the certification program?
Certification program costs and product pricing are discussed during the application review process. Contact us through the application form to begin the conversation. Pricing reflects the clinical education program, ongoing continuing education, directory listing, and product access infrastructure.
How long does the certification program take?
The six-module self-paced program can be completed in approximately 4-6 hours of focused study. Assessment and review typically occurs within 5-7 business days of module completion. Practitioners with an existing scientific background in cell biology or regenerative medicine typically complete the program more quickly.
What regulatory framework governs the use of this preparation?
This is covered in detail in Module 5 of the certification program. The general framework is that EV and exosome preparations fall under FDA oversight as HCT/P (human cells, tissues, and cellular and tissue-based products) under 21 CFR 1271, with further classification depending on the extent of manipulation and intended use. Module 5 covers how to position educational conversations with patients and how to administer preparations within applicable regulatory constraints. Practitioners are responsible for understanding and complying with the regulations applicable in their jurisdiction.
Can I review the science before applying?
The full science is available on this site before you apply. Start with Why 3D MSCs, continue through Why 3D Exosomes, Xenofree Standards, Passage Number, and Characterization, and browse the literature library. The certification program goes deeper on each topic, but this site provides the conceptual foundation. We encourage practitioners to read it before applying — it confirms that the science aligns with your standards before you invest in the process.
How does the provider directory work for patient referrals?
Certified providers are listed in the public provider directory with their name, specialty, and location. Patients searching for certified practitioners by ZIP code, specialty, and search radius are directed to matching providers. Directory listing is maintained as long as certification is current. Listings include only information the practitioner provides and consents to display.